Company Name:uniQure NV
CEO: Matthew C. Kapusta

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: NL

Description: uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.


Key numbers

Market Capitalization:1611808362
Shares Outstanding: 42742200
Float: 33567501
Next Earning Date:2020-11-03
TTm EPS: -2.9895
TTm Dividend Rate:
200 days moving average:56.5
50 days moving average: 54.36
One day percent Change: 2.06



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,